Jeffery Gordon MD, Presenter: Nothing to Disclose

Sanjay Misra MD, Abstract Co-Author: Nothing to Disclose

C. Michael Johnson MD, Abstract Co-Author: Nothing to Disclose

Enrique A. Sabater MD, Abstract Co-Author: Nothing to Disclose

James C. Andrews MD, Abstract Co-Author: Nothing to Disclose

Jayawant N Mandrekar PHD, Abstract Co-Author: Nothing to Disclose

Michael A. McKusick MD, Abstract Co-Author: Nothing to Disclose

Anthony Wayne Stanson MD, Abstract Co-Author: Nothing to Disclose

Ian R McPhail MD, Abstract Co-Author: Nothing to Disclose

Haraldur Bjarnason MD, Abstract Co-Author: Nothing to Disclose

et al, Abstract Co-Author: Nothing to Disclose

To determine the utility of percutaneous intervention in Chronic Mesenteric ischemia.

After IRB approval, a retrospective review of all patients who presented with chronic mesenteric ischemia and were treated percutaneously from April 1990 to January 2004 was performed. 41 patients were examined, 24 female and 17 male. From 1990 to 1996, angioplasty alone was performed, and since 1997, angioplasty and stenting were performed. Stenting was performed typically for ostial stenoses, residual stenoses after angioplasty greater than 30%, or dissection. Estimates of survival, long term clinical success, and patency were calculated using the Kaplan-Meier method. Group differences in these outcomes were assessed using the log rank test.

A total of 58 vessels were treated in 41 patients, 17 male and 24 female. The distribution of intervention was as follows: 33 SMA (13 PTA, 20 stents), 17 celiac axis (6PTA, 11 stents), 5 IMA (4PTA, 1 stent), and 3 aorto-mesenteric grafts (PTA). The mean follow up time was 28 months. The primary patency and primary assisted patency at 2 years was 89% (76%, 100%) and 87% (72%, 98%), respectively. The survival of one vessel and more than one vessel treatment at 2 years was 79% (62%, 100%) and 66% (41%, 100%), respectively. The survival of PTA alone and PTA with stent at 2 years was 78% (59%, 100%) and 74% (52%, 100%), respectively. The overall patency at 2 years was 89% (77%, 100%). The overall survival at 2 years was 77% (61%, 93%). The procedural complications consisted of 4 dissections, 1 pseudoaneurysm, and 1 hematoma.

Percutaneous interventions are a safe alternative treatment for chronic mesenteric ischemia and can be performed with minimal complications.

Gordon, J, Misra, S, Johnson, C, Sabater, E, Andrews, J, Mandrekar, J, McKusick, M, Stanson, A, McPhail, I, Bjarnason, H, et al, , Endovascular Treatment of Chronic Mesenteric Ischemia.  Radiological Society of North America 2005 Scientific Assembly and Annual Meeting, November 27 - December 2, 2005 ,Chicago IL. http://archive.rsna.org/2005/4408988.html